CM
Caption Management Portfolio holdings
AUM
$1.09B
1-Year Return
4.13%
This Quarter Return
+3.19%
1 Year Return
+4.13%
3 Year Return
+12.18%
5 Year Return
+25.84%
10 Year Return
–
AUM
$2.42B
AUM Growth
+$1.49B
(+160%)
Cap. Flow
+$1.48B
Cap. Flow
% of AUM
61.28%
Top 10 Holdings %
Top 10 Hldgs %
70.12%
Holding
1,093
New
281
Increased
100
Reduced
101
Closed
199
Top Buys
| 1 |
NVIDIA
NVDA
|
$545M |
| 2 |
Tesla
TSLA
|
$404M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
$142M |
| 4 |
Alphabet (Google) Class C
GOOG
|
$130M |
| 5 |
Amazon
AMZN
|
$121M |
Top Sells
| 1 |
SPDR S&P Regional Banking ETF
KRE
|
$61.4M |
| 2 |
Verizon
VZ
|
$57.9M |
| 3 |
Broadcom
AVGO
|
$19.1M |
| 4 |
Frontier Communications
FYBR
|
$16.1M |
| 5 |
Citigroup
C
|
$16.1M |
Sector Composition
| 1 | Technology | 32.28% |
| 2 | Consumer Discretionary | 26.12% |
| 3 | Communication Services | 15.12% |
| 4 | Healthcare | 8.48% |
| 5 | Financials | 6.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Teva Pharmaceuticals
TEVA
$21.7B
| $1.02M | 0.01% |
46,136
-138,164
| -75% | -$3.05M |
|
202
Pacira BioSciences
PCRX
$1.19B
| $1.01M | 0.01% |
+53,844
| New | +$1.01M |
|
203
Viking Therapeutics
VKTX
$3.03B
| $1.01M | 0.01% |
25,000
-24,500
| -49% | -$986K |
|
204
CRISPR Therapeutics
CRSP
$4.99B
| $1.01M | 0.01% |
25,555
+24,955
| +4,159% | +$982K |
|
205
PENN Entertainment
PENN
$2.99B
| $991K | 0.01% |
+50,000
| New | +$991K |
|
206
Archer Daniels Midland
ADM
$30.2B
| $990K | 0.01% |
+19,600
| New | +$990K |
|
207
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$3.51B
| $979K | 0.01% |
+36,500
| New | +$979K |
|
208
Keros Therapeutics
KROS
$633M
| $969K | 0.01% |
+61,200
| New | +$969K |
|
209
Valero Energy
VLO
$48.7B
| $956K | 0.01% |
7,800
-39,700
| -84% | -$4.87M |
|
210
AdaptHealth
AHCO
$1.29B
| $952K | 0.01% |
100,000
-33,073
| -25% | -$315K |
|
211
Amplify Transformational Data Sharing ETF
BLOK
$1.16B
| $951K | 0.01% |
+22,030
| New | +$951K |
|
212
Douglas Elliman
DOUG
$257M
| $949K | 0.01% |
568,342
-303,727
| -35% | -$507K |
|
213
Kroger
KR
$44.8B
| $948K | 0.01% |
+15,500
| New | +$948K |
|
214
Amkor Technology
AMKR
$6.09B
| $904K | 0.01% |
35,200
+33,900
| +2,608% | +$871K |
|
|
XIFR
215
XPLR Infrastructure, LP
XIFR
$976M
| $901K | 0.01% |
50,601
+38,846
| +330% | +$691K |
|
216
Compass
COMP
$5.07B
| $898K | 0.01% |
+153,500
| New | +$898K |
|
217
Avidity Biosciences
RNA
$6.48B
| $896K | 0.01% |
+30,800
| New | +$896K |
|
218
Peabody Energy
BTU
$2.33B
| $895K | 0.01% |
42,760
-209,395
| -83% | -$4.38M |
|
219
Amicus Therapeutics
FOLD
$2.46B
| $895K | 0.01% |
+95,000
| New | +$895K |
|
220
Upstart Holdings
UPST
$6.44B
| $893K | 0.01% |
+14,500
| New | +$893K |
|
221
Evolent Health
EVH
$1.11B
| $888K | 0.01% |
78,972
+78,958
| +563,986% | +$888K |
|
222
WESCO International
WCC
$10.7B
| $887K | 0.01% |
+4,900
| New | +$887K |
|
223
Boston Scientific
BSX
$159B
| $878K | 0.01% |
+9,833
| New | +$878K |
|
224
ON Semiconductor
ON
$20.1B
| $876K | 0.01% |
13,900
-4,000
| -22% | -$252K |
|
225
HealthEquity
HQY
$7.88B
| $875K | 0.01% |
+9,120
| New | +$875K |
|